AUTHORS
Claudia C Bippes, Corina Kohler, Esther Garcia-Tirado, Reto Burri, Tina Frauenknecht, Marie-Apolline Gerard, Marie Salat, Roy Allenspach, Cavit Agca, Zongsong Wu, Andrea Trost, Barbara Bogner, Peter Meyer, Hendrik P N Scholl, Herbert Reitsamer, Josef Flammer, Albert Neutzner
Mol Ther. 2022 Feb 2;30(2):855-867. doi: 10.1016/j.ymthe.2021.09.018. Epub 2021 Sep 20.
ABSTRACT
Cell-penetrating peptides (CPPs) hold great promise for intracellular delivery of therapeutic proteins. However, endosomal entrapment of transduced cargo is a major bottleneck hampering their successful application. While developing a transducible zinc finger protein-based artificial transcription factor targeting the expression of endothelin receptor A, we identified interaction between the CPP and the endosomal membrane or endosomal entanglement as a main culprit for endosomal entrapment. To achieve endosomal disentanglement, we utilized endosome-resident proteases to sever the artificial transcription factor from its CPP upon arrival inside the endosome. Using this approach, we greatly enhanced the correct subcellular localization of the disentangled artificial transcription factor, significantly increasing its biological activity and distribution in vivo. With rational engineering of proteolytic sensitivity, we propose a new design principle for transducible therapeutic proteins, helping CPPs attain their full potential as delivery vectors for therapeutic proteins.
PMID:34547467 | PMC:PMC8821953 | DOI:10.1016/j.ymthe.2021.09.018
